What the Wegovy pill and injection have in common

Before examining the differences, it helps to understand what both formulations share - because the answer is: quite a lot.

Both the Wegovy pill and the Wegovy injection contain semaglutide as their active ingredient. Semaglutide is a GLP-1 receptor agonist, meaning it mimics a naturally occurring gut hormone that regulates appetite, improves feelings of fullness, and slows stomach emptying. As a result of these combined effects, calorie intake falls and weight loss follows - steadily, and in a way that proves difficult to achieve through lifestyle changes alone for many people.

Furthermore, both formulations require a prescription from a UK-registered prescriber. Neither is available over the counter. Both follow a gradual dose escalation schedule - starting at a low dose and increasing every 30 days - to allow the body to adjust and minimise gastrointestinal side effects. Both are manufactured by Novo Nordisk and share the same licensed indication: the management of obesity and overweight in adults with a BMI of 30 or above, or 27.5 or above with a weight-related health condition.

In short, the choice between the Wegovy pill and the Wegovy injection is not a choice between two different drugs. It is a choice between two different ways of taking the same drug.

Efficacy: are Wegovy pills as effective as injections?

This is the most important question for most people - and the clinical evidence gives a clear, encouraging answer. Yes, the Wegovy pill produces weight loss results that are broadly comparable to the injection.

The OASIS 4 clinical trial, which evaluated oral semaglutide 25mg in adults with obesity or overweight, showed approximately 16.6% average body weight reduction over 64 weeks. By comparison, the STEP 1 trial for the Wegovy injection showed approximately 15% average body weight reduction at 68 weeks. Both trials involved adults without type 2 diabetes and both combined treatment with lifestyle intervention.

Notably, the pill showed marginally higher average weight loss than the injection in trial data. This does not necessarily mean the pill is more effective in every individual - trial populations, study designs, and participant characteristics all influence outcomes. However, it does mean that anyone concerned that swapping an injection for a tablet would mean settling for inferior results can set that concern aside. The evidence simply does not support it.

Key differences between the Wegovy pill and injection

The benefits of the Wegovy pill over the injection

For many people, the Wegovy pill represents a genuinely better option in practical terms - even if clinical efficacy is comparable. Here are the most significant advantages.

No needles - ever

The most obvious benefit is the complete absence of injections at any point during treatment. Needle phobia affects an estimated 20 to 25% of adults and represents one of the most common reasons people delay or decline weight loss treatment despite wanting the clinical benefits. With the Wegovy pill, that barrier simply does not exist. Treatment starts with a tablet and stays a tablet throughout.

No cold-chain storage

Unlike the Wegovy injection - which must travel in temperature-controlled packaging and go straight into the fridge on arrival - the Wegovy pill stores at room temperature in its original bottle. This matters for travel, for people who lack reliable fridge access, and for anyone who finds the logistics of injectable treatment cumbersome over the long term.

No sharps disposal

Injectable GLP-1 treatment requires a sharps disposal bin, collection arrangements, and ongoing attention to safe needle disposal. With the Wegovy pill, none of that applies. The medication simply goes in the bin when the bottle is empty.

Discreet and straightforward

Taking a daily tablet is something most people do without a second thought. By contrast, weekly self-injection - however simple the pen design - remains a deliberate, visible act that some patients find difficult to normalise over months of treatment. Moreover, travelling with injectable medication, managing fridge access away from home, and explaining a sharps bin to housemates or family members all add complexity that the pill avoids entirely.

How Mounjaro compares to the Wegovy pill and injection

Any honest comparison of semaglutide options should also include Mounjaro - because for patients primarily focused on maximum weight loss, it changes the picture significantly.

Mounjaro (tirzepatide) works differently from both Wegovy formulations. Rather than acting on GLP-1 receptors alone, tirzepatide activates both GLP-1 and GIP receptors - a dual mechanism that produces greater appetite suppression and, consequently, greater average weight loss. Trials have shown between 20 and 22.5% average body weight reduction, which is meaningfully higher than either semaglutide option.

However, Mounjaro currently only comes as a weekly injection. Therefore, for patients who specifically want to avoid needles, it is not an option at this point. For those willing to inject weekly and seeking the strongest available clinical outcome, Mounjaro currently sits at the top of the evidence base. As a result, the choice often becomes: maximum efficacy with injection (Mounjaro), good efficacy with injection and simpler logistics (Wegovy injection), or comparable efficacy with no needles at all (Wegovy pill).

Side effects: Wegovy pill vs injection

Because both formulations deliver semaglutide, their side effect profiles are broadly similar. The most common effects - nausea, vomiting, diarrhoea, constipation, headache, and fatigue - occur with both the pill and the injection and tend to be most noticeable during the early weeks of treatment and following each dose increase.

In practice, side effects are most commonly triggered by moving up doses too quickly. The gradual titration schedule for both formulations addresses this directly. Additionally, prescribers at Dr Weightmans manage side effects by finding the highest dose a patient can comfortably tolerate rather than pushing to the maximum regardless. Staying well hydrated and using rehydration salts can also ease gastrointestinal discomfort during the early stages.

One practical difference worth noting: because the Wegovy pill relies on stomach absorption via the SNAC mechanism, anything that interferes with an empty stomach - eating too soon, taking the pill with the wrong liquid, or not waiting long enough - can reduce absorption and potentially amplify the effects of an inconsistent dose. By contrast, the injection delivers a consistent dose regardless of food timing. Consequently, patients who struggle with strict morning routines may find the injection's side effect profile easier to manage simply because absorption is more predictable.

Which option suits you best

Rather than identifying one option as universally superior, the more useful approach is matching each option to the person most likely to benefit from it. Below is a practical guide based on common patient situations.

Ultimately, the best treatment is the one you can take consistently over the long term. A theoretically superior option that you find difficult to maintain will underperform a slightly less effective option that fits naturally into your life.

Can you switch between the Wegovy pill and injection?

Yes - switching between the two formulations is possible and may suit patients whose circumstances change during treatment. However, the titration schedules differ between the pill and injection, so a prescriber review is always necessary before switching. A prescriber needs to assess where you are in your current treatment and determine the appropriate starting dose for the new formulation.

At Dr Weightmans, switching between treatments always involves a clinical assessment before we issue a new prescription. Patients who want to discuss moving from the Wegovy injection to the pill - or vice versa - can raise this through their account chat function, by telephone, or by email, and their prescriber will advise accordingly.

Furthermore, patients currently on Mounjaro who want to explore switching to a Wegovy formulation, or the other way round, should also raise this with their prescriber rather than making the change unilaterally. Different drugs, different dosing schedules, and different mechanisms mean the transition needs clinical oversight.

Summary: Wegovy pill vs injection - the key points

• Both the Wegovy pill and injection contain semaglutide - the same active ingredient
• Clinical trials show approximately 16.6% weight loss for the pill and 15% for the injection - broadly comparable results
• The pill requires no needles, no refrigeration, and no sharps disposal
• The injection needs only once-weekly dosing with no food restrictions - simpler to time
• The pill demands strict daily timing: empty stomach, plain water, 30-minute wait before eating
• Mounjaro (tirzepatide) outperforms both at 20 to 22.5% - but requires weekly injection
• Neither option is universally better - the right choice depends on your lifestyle and preferences
• Switching between formulations is possible but always requires a prescriber review first
• All three options - Wegovy pill, Wegovy injection, and Mounjaro - are available through Dr Weightmans